Clinical Trial to Evaluate Pharmacokinetics,Safety and Immunogenicity of Single Injection of CDP1 to Healthy Volunteers Compared to Erbitux

NCT03881787 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: anti-EGFR monoclonal antibody
DRUG: Cetuximab injection

Sponsor

Dragonboat Biopharmaceutical Company Limited

Collaborators

[object Object]
[object Object]